<SEC-DOCUMENT>0001213900-15-000762-index.html : 20150206
<SEC-HEADER>0001213900-15-000762.hdr.sgml : 20150206
<ACCEPTANCE-DATETIME>20150206132257
ACCESSION NUMBER:		0001213900-15-000762
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20150206
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150206
DATE AS OF CHANGE:		20150206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36374
		FILM NUMBER:		15583505

	BUSINESS ADDRESS:	
		STREET 1:		546 5TH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-300-2131

	MAIL ADDRESS:	
		STREET 1:		546 5TH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k020615_actiniumpharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k020615_actiniumpharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>f8k020615ex1i_actinium.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
Document 2 - file: f8k020615ex1i_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>f8k020615ex4i_actinium.htm
<DESCRIPTION>FORM OF WARRANT ISSUED TO THE INVESTORS
<TEXT>
Document 3 - file: f8k020615ex4i_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>f8k020615ex5i_actinium.htm
<DESCRIPTION>OPINION OF HISCOCK & BARCLAY, LLP.
<TEXT>
Document 4 - file: f8k020615ex5i_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>f8k020615ex99i_actinium.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY ACTINIUM PHARMACEUTICALS, INC. DATED FEBRUARY 6, 2015.
<TEXT>
Document 5 - file: f8k020615ex99i_actinium.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: image_002.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: image_001.gif

</DOCUMENT>
</SEC-DOCUMENT>